Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- Korea Research Foundation
- Target Recruit Count
- 41
- Registration Number
- NCT00879775
- Locations
- 🇰🇷
National Health Insurance Corporation Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
News
No news found